Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    PR Mobile Headlines    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for June 07, 2008 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Cloning Hairs Seen As Possible Solution to Baldness
Cloning may soon become the answer to the prevalent problem of baldness in both men and women, with British scientists finding a way to clone hair follicles. 
x-small text small text medium text large text


/24-7PressRelease/ - LONDON, UK, June 07, 2008 - While the common term is male pattern baldness, the problem of becoming bald prematurely is actually fairly common in both men and women. Millions of men and women suffer from this problem, but there might be a solution forthcoming to allow people to regain their old, lustrous locks --- through the controversial technology known as cloning.

The idea behind this, a technique known as "follicular cell implantation," was recently tested on human beings by a British team of researchers. They promptly hailed the procedure as a major advance in the methods available for hair restoration, with the financial backing from the government amounting to 1.9 million.

Theoretically, the therapy could provide limitless replacements for lost hair. According to the team, the procedure could be used to replace hair lost to burns, cancer treatments, or the simple ravages of old age. The researchers estimate that the technology might be available to the average patient within the next five years, in the best-case scenario.

The method involves extracting cells from the skin known as dermal papilla. These cells are known to be responsible for the growth of hair, and are usually extracted from the back of the scalp - where hair growth is known to continue despite losses everywhere else. The cells are placed in a special culture, where they are made to multiply, stimulating them into developing new hair follicles. The technique has also been successfully used to rejuvenate areas that have simply stopped producing hair.

Intercytex, the British company behind this procedure, is among the major companies competing to find a way to reverse the hair loss that affects an estimated 40% of men over the age of 50. They say that over a thousand injections might be required before the number of hair cells in bald patients will show any signs of growth, but believe it would be quicker and less invasive than the current alternative: hair transplants.

According to the team, it only takes a period of eight weeks for the cells to be able to generate millions of themselves in the special culture developed, allowing for rapid re-growth of hair follicles in the skin. Japanese, Italian, and American groups have also reportedly made progress in using cloning as a means of restoring hair growth, particularly through the use of adult stem cells.

Harvey Ong is currently working as a writer-researcher for an online pharmaceutical company. He has also had experience field testing blackjack betting systems and is an amateur poker player.

# # #


Read more Press Releases from Jennifer Alinio:
Other Similar Press Release Topics:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Jennifer Alinio
DrugstoreTM.com

SEO Analyst
305 Vine St.
liverpool, NewYork
USA 10020
Voice: (866)-2051538
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.